Isaac Kim, MD, Urology, New Brunswick, NJ, Robert Wood Johnson University Hospital

IsaacYKimMD

Urology New Brunswick, NJ

Minimally Invasive Surgery, Surgical Oncology

Chief, Urologic Oncology Executive Director, Prostate Cancer Program Rutgers Cancer Institute of New Jersey

Dr. Kim is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kim's full profile

Already have an account?

Summary

  • I am a board certified urologist with clinical and research focus on prostate and kidney cancer. To date, I have performed over 1300 robotic prostatectomies and 200 laparoscopic/robotic nephrectomies. Currently, I am the Interim Chief and Associate Professor of the Division of Urology, Rutgers Robert Wood Johnson Medical School and Chief of the Section of Urologic Oncology and director of the Prostate Cancer Center at the Rutgers Cancer Institute of New Jersey. Since joining RCINJ in 2005, I have developed a thriving clinical practice focused on robotic surgery. Simultaneously, I have established a robust research program focused on the biology of castration-resistant prostate cancer. My most recent study suggests that tumor associated macrophages may be an important component in castration-resistant prostate cancer. My research activity has resulted in more than 100 publications and funding support from the Department of Defense and various philanthropic organizations.

Education & Training

  • The Wharton School of the University of PennsylvaniaMBA, Management, 2015 - 2017
  • University of California Irvine College of Medicine
    University of California Irvine College of MedicineFellowship, Laparoscopy and Robotic Surgery, 2003 - 2005
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Urology, 1999 - 2003
  • National Cancer Institute
    National Cancer InstitutePost-Doctoral Fellowship, Laboratory of Cell Regulation and Carcinogenesis, 2000 - 2001
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Transitional Year, 1997 - 1998
  • Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of MedicineClass of 1997
  • Northwestern University
    Northwestern UniversityPhD, Tumor Cell Biology, 1993 - 1996
  • Northwestern University Graduate SchoolPhD, Integrated Graduate Program in Tumor Cell Biology, 1993 - 1996
  • University of California at BerkeleyB.A., Biochemistry, With High Honors, 1986 - 1990

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2005 - 2023
  • CA State Medical License
    CA State Medical License 2003 - Present
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Award of Hope The Cancer Institute of New Jersey Foundation, 2010
  • Edwin Beer Research Fellowship New York Academy of Medicine, 2006
  • Outstanding Laparoendoscopic Resident Surgeon The Society of Laparoendoscopic Surgeons, 2003
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer Database  
    Parth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology
  • Cytoreductive Prostatectomy: Evidence in Support of a New Surgical Paradigm  
    Izak Faiena, Eric A. Singer, Chris Pumill, and Isaac Y. Kim, Int J Oncology, 1/1/2014
  • Active Surveillance in Men with Low-Risk Prostate Cancer: Current and Future Challenges  
    Christopher Sejong Han, Jaspreet Singh Parihar, and Isaac Yi Kim, American Journal of Clinical and Experimental Urology, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Prostate cancer bone metastases acquire resistanct to androgen deprivation via WNT5A medicated BMP-6 induction
    Isaac Yi Kim, Urological Research Society Annual Meeting, Munich, Germany, 1/18/2014
  • Active Surveillance for Prostate Cancer: Rethinking Prostate-Specific Antigen Density Eligibility Criteria
    Yunsok Ha, Neal Patel, Amirali Salmasi, Eric Singer, Jihyeong Yu, Jeong Hyun Kim, Wun-Jae Kim, Isaac Yi Kim, 109th annual meeting of the American Urological Association, Orlando, FL, 1/16/2014
  • Off-target Effect of Sildenafil is Neuroprotective via Phosphodiesterase Type-4
    Amirali Salmasi, Neal Patel, Geun Taek Lee, Isaac Yi Kim, 109th annual meeting of the American Urological Association, Orlando, FL, 1/16/2014
  • Join now to see all

Lectures

  • Indications for adjuvant radiation following RARP at Rutgers-CINJ 
    Seoul, Korea - 1/7/2015
  • Prostate cancer bone metastases acquire resistance to androgen deprivation via Wnt5a mediate BMP6 induction 
    Vancouver, Canada - 1/19/2014
  • Wnt5A/BMP-6 Loop and Castration Resistance in Prostate Cancer Bone Metastases 
    Dallas, TX - 1/16/2014
  • Join now to see all

Other

  • Robot-Assisted Laparoscopic Radical Prostatectomy 
    Isaac Y. Kim
    1/20/2010
  • Laparoscopy 1 
    Isaac Y. Kim, 26th World Congress Endourology and SWL
    Shanghai, China - 1/30/2008
  • Expression and Regulation of Transforming Growth Factor-B Receptors in Normal and Malignant Prostatic Epithelial Cells 
    Isaac Y. Kim, University Microfilm Inc Dissertation Services
    1/1/1996

Press Mentions

  • Rutgers Cancer Institute of New Jersey Experts Address Prostate Cancer in Wake of Recent Announcement from Television Personality Al Roker
    Rutgers Cancer Institute of New Jersey Experts Address Prostate Cancer in Wake of Recent Announcement from Television Personality Al RokerNovember 6th, 2020
  • Similar Incidence of DNA Damage Response Pathway Alterations Between Localized and Metastatic Prostate Cancer
    Similar Incidence of DNA Damage Response Pathway Alterations Between Localized and Metastatic Prostate CancerMay 3rd, 2019
  • Better Survival Outcomes for Advanced Prostate Cancer Patients Treated with Surgery Followed by Radiation Than with Radiation plus Hormone Therapy
    Better Survival Outcomes for Advanced Prostate Cancer Patients Treated with Surgery Followed by Radiation Than with Radiation plus Hormone TherapySeptember 20th, 2018
  • Join now to see all

Professional Memberships

Other Languages

  • Korean

Hospital Affiliations